Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials.
about
Differentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment.Osteoarthritis year in review 2015: clinical.Re: Kucharz EJ, Kovalenko V, Szántó S, et al. A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes. Curr Med Res Opin 2016;32:997Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, PlacInappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
P2860
Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Risk of bias and brand explain ...... of placebo-controlled trials.
@ast
Risk of bias and brand explain ...... of placebo-controlled trials.
@en
Risk of bias and brand explain ...... of placebo-controlled trials.
@nl
type
label
Risk of bias and brand explain ...... of placebo-controlled trials.
@ast
Risk of bias and brand explain ...... of placebo-controlled trials.
@en
Risk of bias and brand explain ...... of placebo-controlled trials.
@nl
prefLabel
Risk of bias and brand explain ...... of placebo-controlled trials.
@ast
Risk of bias and brand explain ...... of placebo-controlled trials.
@en
Risk of bias and brand explain ...... of placebo-controlled trials.
@nl
P2093
P2860
P921
P356
P1476
Risk of bias and brand explain ...... s of placebo-controlled trials
@en
P2093
Carsten Juhl
Else M Bartels
Patrick Eriksen
Robin Christensen
Roy D Altman
P2860
P304
P356
10.1002/ACR.22376
P50
P577
2014-12-01T00:00:00Z